BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
Holding BNGO?
Track your performance easily

BioNano Genomics (BNGO) Financial Statements

8,966 Followers

BioNano Genomics Financial Overview

BioNano Genomics's market cap is currently ―. The company's EPS TTM is $-5.011; its P/E ratio is -0.06; BioNano Genomics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 7.77M$ 8.77M$ 10.72M$ 9.32M$ 8.66M
Gross Profit$ 2.58M$ 2.82M$ 2.44M$ 2.75M$ 2.31M
EBIT$ -16.12M$ -31.32M$ -39.03M$ -112.46M$ -38.80M
EBITDA$ -12.39M$ -28.95M$ -35.38M$ -108.86M$ -35.60M
Net Income Common Stockholders$ -16.22M$ -31.42M$ -43.89M$ -112.57M$ -38.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.90M$ 28.40M$ 66.70M$ 63.60M$ 77.10M
Total Assets$ 129.36M$ 158.00M$ 214.40M$ 181.90M$ 271.42M
Total Debt$ 27.57M$ 37.87M$ 79.41M$ 10.14M$ 10.66M
Net Debt$ 8.67M$ 9.47M$ 12.71M$ -53.46M$ -66.44M
Total Liabilities$ 49.03M$ 75.22M$ 118.25M$ 62.91M$ 56.63M
Stockholders Equity$ 80.29M$ 82.77M$ 96.16M$ 119.00M$ 214.71M
Cash Flow-
Free Cash Flow$ -21.08M$ -28.13M$ -31.49M$ -24.04M$ -35.93M
Operating Cash Flow$ -21.00M$ -28.10M$ -29.80M$ -24.07M$ -35.90M
Investing Cash Flow$ 28.63M$ 47.59M$ -55.37M$ 31.21M$ 28.79M
Financing Cash Flow$ -1.98M$ -21.62M$ 68.48M$ 12.59M$ 17.88M
Currency in USD

BioNano Genomics Earnings and Revenue History

BioNano Genomics Debt to Assets

BioNano Genomics Cash Flow

BioNano Genomics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis